William Hinshaw - Feb 8, 2022 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
President & CEO, Director
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 05:03 PM
Previous filing
Feb 1, 2022
Next filing
Mar 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +275K $0.00 275K Feb 8, 2022 Common Stock 275K $1.63 Direct F1
transaction AXLA Stock Option (Right to Buy) Award $0 +100K $0.00 100K Feb 8, 2022 Common Stock 100K $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.